Skip to main content
Premium Trial:

Request an Annual Quote

Richard Bender

Signal Genetics has appointed Richard Bender its chief medical officer, effective Sept. 14. He will report directly to Signal President and CEO Samuel Riccitelli. 

Bender has more than 30 years of experience in clinical oncology/hematology and medical diagnostics. Most recently, he consulted for various companies and was a long-term medical affairs consultant for Quest Diagnostics. Previous to that, he was vice president and CMO at Agendia, and before that, he was the medical director of hematology/oncology at Quest in San Juan Capistrano, California. He also held management positions at Johnson & Johnson Pharmaceutical and at Permanente Medical Group.

The Scan

Back as Director

A court has reinstated Nicole Boivin as director of the Max Planck Institute for the Science of Human History, Science reports.

Research, But Implementation?

Francis Collins reflects on his years as the director of the US National Institutes of Health with NPR.

For the False Negatives

The Guardian writes that the UK Health Security Agency is considering legal action against the lab that reported thousands of false negative COVID-19 test results.

Genome Biology Papers Present Epigenetics Benchmarking Resource, Genomic Architecture Maps of Peanuts, More

In Genome Biology this week: DNA methylation data for seven reference cell lines, three-dimensional genome architecture maps of peanut lines, and more.